Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genakumab vs colchicine for prevention of gout flares
CTR20231862Phase 2Completed
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Jun 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of genakumab in gout, sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Jun 2023; status: completed.
02
Drugs
genakumab
03
Conditions
gout
Beyond the preview
Go deeper on CTR20231862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231862.